Trial Profile
A phase I/II trial of AU 105 in patients with sarcoma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 15 Mar 2016
Price :
$35
*
At a glance
- Drugs AU 105 (Primary)
- Indications Sarcoma
- Focus Adverse reactions
- Sponsors Aurora BioPharma
- 15 Mar 2016 New trial record